Terms: = Pancreatic cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB
1218 results:
1. Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
Quintanilha JCF; Sibley AB; Liu Y; Niedzwiecki D; Halabi S; Rogers L; O'Neil B; Kindler H; Kelly W; Venook A; McLeod HL; Ratain MJ; Nixon AB; Innocenti F; Owzar K
BMC Genomics; 2024 May; 25(1):473. PubMed ID: 38745123
[TBL] [Abstract] [Full Text] [Related]
2. Circadian transcriptome of pancreatic adenocarcinoma unravels chronotherapeutic targets.
Sharma D; Adnan D; Abdel-Reheem MK; Anafi RC; Leary DD; Bishehsari F
JCI Insight; 2024 May; 9(9):. PubMed ID: 38716727
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
[TBL] [Abstract] [Full Text] [Related]
4. Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma.
Long AW; Xu H; Santich BH; Guo H; Hoseini SS; de Stanchina E; Cheung NV
J Hematol Oncol; 2024 Apr; 17(1):20. PubMed ID: 38650005
[TBL] [Abstract] [Full Text] [Related]
5. Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer: A phase II trial (HYBRID).
Arai H; Tsuda T; Sunakawa Y; Shimokawa M; Akiyoshi K; Tokunaga S; Shoji H; Kunieda K; Kotaka M; Matsumoto T; Nagata Y; Mizukami T; Mizuki F; Danenberg KD; Boku N; Nakajima TE
Cancer Med; 2024 Apr; 13(7):e7107. PubMed ID: 38591098
[TBL] [Abstract] [Full Text] [Related]
6. Erlotinib combination with a mitochondria-targeted ubiquinone effectively suppresses pancreatic cancer cell survival.
Leung PY; Chen W; Sari AN; Sitaram P; Wu PK; Tsai S; Park JI
World J Gastroenterol; 2024 Feb; 30(7):714-727. PubMed ID: 38515951
[TBL] [Abstract] [Full Text] [Related]
7. Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group.
Weiss L; Fischer LE; Heinemann V; Gieseler F; Hoehler T; Mayerle J; Quietzsch D; Reinacher-Schick A; Schenk M; Seipelt G; Siveke JT; Stahl M; Kaiser U; Waldschmidt DT; Dorman K; Zhang D; Westphalen CB; Boeck S; Haas M
ESMO Open; 2024 Apr; 9(4):102944. PubMed ID: 38503144
[TBL] [Abstract] [Full Text] [Related]
8. Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.
Ge W; Wang Y; Quan M; Mao T; Bischof EY; Xu H; Zhang X; Li S; Yue M; Ma J; Yang H; Wang L; Yu Z; Wang L; Cui J
Mol Cancer; 2024 Mar; 23(1):48. PubMed ID: 38459558
[TBL] [Abstract] [Full Text] [Related]
9. Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer.
Kavgaci G; Dizdar O; Yalcin S
Anticancer Drugs; 2024 Jun; 35(5):459-461. PubMed ID: 38451823
[TBL] [Abstract] [Full Text] [Related]
10. Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight.
Damare R; Engle K; Kumar G
Phytother Res; 2024 May; 38(5):2406-2447. PubMed ID: 38433568
[TBL] [Abstract] [Full Text] [Related]
11. Sense and anti-sense: Role of FAM83A and FAM83A-AS1 in Wnt, egfr, PI3K, EMT pathways and tumor progression.
Zhao C; Li X; Zhang R; Lyu H; Xiao S; Guo D; Ali DW; Michalak M; Chen XZ; Zhou C; Tang J
Biomed Pharmacother; 2024 Apr; 173():116372. PubMed ID: 38432129
[TBL] [Abstract] [Full Text] [Related]
12. SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated egfr ubiquitination and degradation.
Zhang S; Jia X; Dai H; Zhu X; Song W; Bian S; Wu H; Chen S; Tang Y; Chen J; Jin C; Zhou M; Xie H; Zheng S; Song P
Cancer Commun (Lond); 2024 Mar; 44(3):384-407. PubMed ID: 38407942
[TBL] [Abstract] [Full Text] [Related]
13. Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer - Results of a phase 1b clinical trial.
Zhang D; Benedikt Westphalen C; Quante M; Waldschmidt DT; Held S; Kütting F; Dorman K; Heinrich K; Weiss L; Boukovala M; Haas M; Boeck S; Heinemann V; Probst V
Eur J Cancer; 2024 Apr; 201():113926. PubMed ID: 38401449
[TBL] [Abstract] [Full Text] [Related]
14. Cannabigerol Induces Autophagic Cell Death by Inhibiting egfr-RAS Pathways in Human pancreatic Ductal Adenocarcinoma Cell Lines.
Zeppa L; Aguzzi C; Morelli MB; Marinelli O; Giangrossi M; Luongo M; Amantini C; Santoni G; Nabissi M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396679
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptomic Signature of 3D Hierarchical Porous Chip Enriched Exosomes for Early Detection and Progression Monitoring of Hepatocellular Carcinoma.
Yi K; Wang Y; Rong Y; Bao Y; Liang Y; Chen Y; Liu F; Zhang S; He Y; Liu W; Zhu C; Wu L; Peng J; Chen H; Huang W; Yuan Y; Xie M; Wang F
Adv Sci (Weinh); 2024 Apr; 11(14):e2305204. PubMed ID: 38327127
[TBL] [Abstract] [Full Text] [Related]
16. Anti-collagenase, Anti-elastase, Anti-urease, and Anti-cancer Potentials of Isokaempferide as Natural Compound: In vitro and in silico Study.
Yin Q; Zhang H; Huang T; Liu B; Negm S; El-Kott AF
J Oleo Sci; 2024; 73(2):187-199. PubMed ID: 38311409
[TBL] [Abstract] [Full Text] [Related]
17. Role of bio-flavonols and their derivatives in improving mitochondrial dysfunctions associated with pancreatic tumorigenesis.
Sharma V; Arora A; Bansal S; Semwal A; Sharma M; Aggarwal A
Cell Biochem Funct; 2024 Jan; 42(1):e3920. PubMed ID: 38269510
[TBL] [Abstract] [Full Text] [Related]
18. PW06 suppresses cancer cell metastasis in human pancreatic carcinoma MIA PaCa-2 cells via the inhibitions of p-Akt/mTOR/NF-κB and MMP2/MMP9 signaling pathways in vitro.
Huang YP; Yeh CA; Ma YS; Chen PY; Lai KC; Lien JC; Hsieh WT
Environ Toxicol; 2024 May; 39(5):2768-2781. PubMed ID: 38264921
[TBL] [Abstract] [Full Text] [Related]
19. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
20. Real-world outcomes associated with afatinib use in patients with solid tumors harboring NRG1 gene fusions.
Liu SV; Frohn C; Minasi L; Fernamberg K; Klink AJ; Gajra A; Savill KMZ; Jonna S
Lung Cancer; 2024 Feb; 188():107469. PubMed ID: 38219288
[TBL] [Abstract] [Full Text] [Related]
[Next]
